The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Prostate Cancer 101
By Dr. Jordan Ciuro
Comprehensive prostate cancer overview covering types, risk factors, symptoms, screening, treatment options, disparities, and expert-reviewed insights.
Prostate Cancer 101
By Dr. Jordan Ciuro
Comprehensive prostate cancer overview covering types, risk factors, symptoms, screening, treatment options, disparities, and expert-reviewed insights.
Prostate Cancer 101
By Dr. Jordan Ciuro
Comprehensive prostate cancer overview covering types, risk factors, symptoms, screening, treatment options, disparities, and expert-reviewed insights.
Skin Cancer 101
By The Cancer News Team
A comprehensive guide to skin cancer, covering types, symptoms, risk factors, prevention, treatment, and health disparities with up-to-date statistics for 2025.
Skin Cancer 101
By The Cancer News Team
A comprehensive guide to skin cancer, covering types, symptoms, risk factors, prevention, treatment, and health disparities with up-to-date statistics for 2025.
Skin Cancer 101
By The Cancer News Team
A comprehensive guide to skin cancer, covering types, symptoms, risk factors, prevention, treatment, and health disparities with up-to-date statistics for 2025.
PD-1 Therapy Explained: The Treatment Behind Jerry Jones’ Cancer Recovery
By The Cancer News Team
Dallas Cowboys owner Jerry Jones credits PD-1 immunotherapy with saving his life from advanced melanoma, highlighting how checkpoint inhibitors are transforming cancer treatment.
PD-1 Therapy Explained: The Treatment Behind Jerry Jones’ Cancer Recovery
By The Cancer News Team
Dallas Cowboys owner Jerry Jones credits PD-1 immunotherapy with saving his life from advanced melanoma, highlighting how checkpoint inhibitors are transforming cancer treatment.
PD-1 Therapy Explained: The Treatment Behind Jerry Jones’ Cancer Recovery
By The Cancer News Team
Dallas Cowboys owner Jerry Jones credits PD-1 immunotherapy with saving his life from advanced melanoma, highlighting how checkpoint inhibitors are transforming cancer treatment.
What Ryne Sandberg’s Story Reminds Us About Prostate Cancer
By The Cancer News Team
Baseball legend Ryne Sandberg’s battle with metastatic prostate cancer highlights the importance of early detection, awareness, and prevention for this common men’s cancer.
What Ryne Sandberg’s Story Reminds Us About Prostate Cancer
By The Cancer News Team
Baseball legend Ryne Sandberg’s battle with metastatic prostate cancer highlights the importance of early detection, awareness, and prevention for this common men’s cancer.
What Ryne Sandberg’s Story Reminds Us About Prostate Cancer
By The Cancer News Team
Baseball legend Ryne Sandberg’s battle with metastatic prostate cancer highlights the importance of early detection, awareness, and prevention for this common men’s cancer.
New Biomarkers Predict Chemotherapy Resistance Across Multiple Cancer Types
By The Cancer News Team
New research identifies chromosomal instability (CIN) biomarkers that predict chemotherapy resistance across multiple cancer types, offering a breakthrough in precision oncology.
New Biomarkers Predict Chemotherapy Resistance Across Multiple Cancer Types
By The Cancer News Team
New research identifies chromosomal instability (CIN) biomarkers that predict chemotherapy resistance across multiple cancer types, offering a breakthrough in precision oncology.
New Biomarkers Predict Chemotherapy Resistance Across Multiple Cancer Types
By The Cancer News Team
New research identifies chromosomal instability (CIN) biomarkers that predict chemotherapy resistance across multiple cancer types, offering a breakthrough in precision oncology.
FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma
By Prakash Ambady, MD
FDA grants accelerated approval to dordaviprone, the first systemic therapy for diffuse midline glioma with an H3 K27M mutation, offering new hope for patients after progression on prior treatment.
FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma
By Prakash Ambady, MD
FDA grants accelerated approval to dordaviprone, the first systemic therapy for diffuse midline glioma with an H3 K27M mutation, offering new hope for patients after progression on prior treatment.
FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma
By Prakash Ambady, MD
FDA grants accelerated approval to dordaviprone, the first systemic therapy for diffuse midline glioma with an H3 K27M mutation, offering new hope for patients after progression on prior treatment.
Lung Cancer Prevention Strategies and Latest Therapies: World Lung Cancer Day Awareness 2025
By The Cancer News Team
Explore lung cancer prevention strategies, cutting-edge therapies, and expert insights from leading oncologists as we mark World Lung Cancer Day 2025.
Lung Cancer Prevention Strategies and Latest Therapies: World Lung Cancer Day Awareness 2025
By The Cancer News Team
Explore lung cancer prevention strategies, cutting-edge therapies, and expert insights from leading oncologists as we mark World Lung Cancer Day 2025.
Lung Cancer Prevention Strategies and Latest Therapies: World Lung Cancer Day Awareness 2025
By The Cancer News Team
Explore lung cancer prevention strategies, cutting-edge therapies, and expert insights from leading oncologists as we mark World Lung Cancer Day 2025.
Is Choosing Palliative Care Giving Up?
By Matthew Meranda, DO
Palliative care isn’t giving up—it’s a compassionate, patient-centered specialty focused on improving quality of life for those facing serious illness.
Is Choosing Palliative Care Giving Up?
By Matthew Meranda, DO
Palliative care isn’t giving up—it’s a compassionate, patient-centered specialty focused on improving quality of life for those facing serious illness.
Is Choosing Palliative Care Giving Up?
By Matthew Meranda, DO
Palliative care isn’t giving up—it’s a compassionate, patient-centered specialty focused on improving quality of life for those facing serious illness.
Actor Robert Lowe Advocates for Increased Patient Participation in Cancer Clinical Trials
By The Cancer News Team
Actor Rob Lowe partners with Eli Lilly to raise awareness about cancer clinical trials, sharing a personal story of loss and hope to encourage patient advocacy and informed participation.
Actor Robert Lowe Advocates for Increased Patient Participation in Cancer Clinical Trials
By The Cancer News Team
Actor Rob Lowe partners with Eli Lilly to raise awareness about cancer clinical trials, sharing a personal story of loss and hope to encourage patient advocacy and informed participation.
Actor Robert Lowe Advocates for Increased Patient Participation in Cancer Clinical Trials
By The Cancer News Team
Actor Rob Lowe partners with Eli Lilly to raise awareness about cancer clinical trials, sharing a personal story of loss and hope to encourage patient advocacy and informed participation.
New Study Shows At-Home Cervical Cancer Screening Kits Outperform Office-Based Approach in Under-Resourced Health Care Setting
By The Cancer News Team
A landmark clinical trial shows mailed at-home cervical cancer screening kits significantly boost participation among underserved groups, addressing cancer health disparities and advancing global cervical cancer prevention efforts.
New Study Shows At-Home Cervical Cancer Screening Kits Outperform Office-Based Approach in Under-Resourced Health Care Setting
By The Cancer News Team
A landmark clinical trial shows mailed at-home cervical cancer screening kits significantly boost participation among underserved groups, addressing cancer health disparities and advancing global cervical cancer prevention efforts.
New Study Shows At-Home Cervical Cancer Screening Kits Outperform Office-Based Approach in Under-Resourced Health Care Setting
By The Cancer News Team
A landmark clinical trial shows mailed at-home cervical cancer screening kits significantly boost participation among underserved groups, addressing cancer health disparities and advancing global cervical cancer prevention efforts.